Structure Therapeutics In... (GPCR)

NASDAQ: GPCR · Real-Time Price · USD

27.09

-0.24 (-0.88%)

At close: May 02, 2025, 3:59 PM

27.93

3.10%

After-hours: May 02, 2025, 05:42 PM EDT

Structure Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Net Income	-122.48M	-110.68M	-100.56M	-97.81M	-89.79M	-76.99M	-65.55M	-56.22M	-51.32M	-39.46M	-27.04M	-13.09M	-13.36K
Depreciation & Amortization	1.43M	1.44M	1.25M	1.09M	503.92K	295K	292K	277K	277K	205.07K	129.07K	70.07K	66.00
Stock-Based Compensation	18.79M	15.06M	10.9M	8.4M	8.19M	6.72M	5.49M	4.43M	2.51M	1.89M	1.26M	620.94K	937.00
Other Working Capital	-3.84M	-2.39M	-1.15M	1.62M	7.85M	6.18M	204K	-3.31M	815K	1.14M	1.98M	371.44K	439.00
Other Non-Cash Items	-11.54M	-7.06M	-4.59M	-1.75M	-977.2K	-710K	-893K	-885K	-558K	254.06K	161.06K	65.06K	65.00
Deferred Income Tax	n/a	-1.27M	-2.93M	-4.58M	-4.58M	-2.9M	-1.51M	n/a	6.01K	-403.99K	-123.99K	6.01K	4.00
Change in Working Capital	-534K	2.73M	-4.7M	3.49M	6.98M	3.8M	2.47M	-514K	2.97M	3.41M	1.99M	-1.19M	1.52K
Operating Cash Flow	-116.58M	-102.02M	-102.88M	-93.38M	-79.67M	-69.78M	-59.71M	-52.91M	-46.12M	-34.1M	-23.62M	-13.53M	-10.76K
Capital Expenditures	-1.29M	-2.43M	-2.57M	-2.33M	-2.17M	-1.08M	-334K	-90K	-155K	-84.12K	-12.12K	-65.12K	-120
Cash Acquisitions	n/a	-37.57K	-68.52K	n/a	n/a	27.16K	74.69K	22.3K	22.3K	32.71K	16.13K	n/a	n/a
Purchase of Investments	-702.52M	-807.27M	-567.02M	-259.55M	-417.77M	-189.96M	-221.01M	-271.9M	-123.45M	-114.27M	-68.28M	-41.65M	n/a
Sales Maturities Of Investments	344.9M	236.68M	216M	43.82M	151.46M	113.78M	97.3M	200.58M	61.5M	41.9M	12.5M	2M	1.2K
Other Investing Acitivies	1.58K	1.58K	-242.54K	-35.99K	-86.59K	-76.17K	-123.71K	-71.32K	-61.95K	-71.17K	-54.58K	-38.45K	1.2K
Investing Cash Flow	-358.91M	-573.03M	-353.86M	-218.06M	-268.49M	-77.26M	-124.04M	-71.41M	-62.11M	-72.45M	-55.79M	-39.72M	1.08K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-5.99K	-5.99K	-5.99K	-5.99K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-28.22K	-19.01M	-17.78M	-17.49M	-20.77M	-2.71M	-3.44M	27.89M	29.01M	29.21M	29.47M	-1.56M	-115K
Financial Cash Flow	514.57M	795.92M	797.15M	282.85M	451.87M	169.59M	168.85M	200.19M	29.01M	29.33M	29.59M	-1.45M	-115
Net Cash Flow	39.73M	121.5M	341.05M	-28.66M	103.7M	22.54M	-14.9M	75.87M	-79.21M	-77.22M	-49.83M	-54.69M	-9.79K
Free Cash Flow	-117.87M	-104.46M	-105.45M	-95.72M	-81.84M	-70.87M	-60.04M	-53M	-46.27M	-34.19M	-23.64M	-13.59M	-10.88K